HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rep. Pallone Readying Cosmetics Bill Following EWG Nail Ingredient Study

This article was originally published in The Rose Sheet

Executive Summary

A new study from the Environmental Working Group and Duke University links common nail polish ingredient triphenyl phosphate to elevated levels in user's blood of a metabolite suspected of endocrine disruption. The Personal Care Products Council calls the study "speculative" and "misleading," while Rep. Frank Pallone, D-N.J., says its results signal a need for new legislation to update cosmetics regulations.

You may also be interested in...

California DTSC Nominates TPHP In Nail Products As Possible Priority For Alternatives Analysis

California is taking a closer look at the safety of four potentially harmful ingredients in nail products and has named triphenyl phosphate specifically as a possible Priority Product under the state’s Safer Consumer Products regulation.

CIR's Draft Review Priorities Reflect International Activity, NGO Targets

The Cosmetic Ingredient Review Expert Panel is set to finalize its list of ingredient priorities for review in 2017 at its June 6-7 meeting in Washington.

Teen Study Promoting Switch To 'Free Of' Cosmetics Causes Usual Row

Teenage girls who used personal-care products free of phthalates, parabens, triclosan and benzophenone-3 showed reduced levels of those substances in their urine after three days, according to a study published in Environmental Health Perspectives. Industry's and NGOs' divergent views on the study reflect continuing disagreement as to how chemical safety should be assessed.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts